A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.

about

A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.

Item

http://www.wikidata.org/entity/Q46240327

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A Limited Immunohistochemical ...... Adenomas for Routine Practice.

@en

A Limited Immunohistochemical ...... Adenomas for Routine Practice.

@nl

type

Item

label

A Limited Immunohistochemical ...... Adenomas for Routine Practice.

@en

A Limited Immunohistochemical ...... Adenomas for Routine Practice.

@nl

prefLabel

A Limited Immunohistochemical ...... Adenomas for Routine Practice.

@en

A Limited Immunohistochemical ...... Adenomas for Routine Practice.

@nl

P1476

A Limited Immunohistochemical ...... Adenomas for Routine Practice.

@en

P2093

Brent K Larson

http://www.w3.org/2001/XMLSchema#string

Maha Guindi

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular pathogenesis of hepatic adenomas and its implications for surgical management

Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases

Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.

Telangiectatic adenoma: an entity associated with increased body mass index and inflammation.

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

Clinicopathological analysis of hepatocellular adenoma according to new bordeaux classification: report of eight korean cases.

Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.

The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre.

Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics.

Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.

P304

557-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJCP/AQX010

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28472207

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry